東陽光藥(01558.HK):利伐沙班片已獲中國審批上市 2021-05-25T10:49:20-04:00May 25th, 2021| share this article!【財華社訊】東陽光藥(01558.HK)公佈,該公司自廣東東陽光藥業收購之產品利伐沙班片(10mg、15mg及20mg)已獲中國國家藥品監督管理局審批完畢並獲准上市。 Read More share this article! Related Posts Japan, EU universities to partner on fostering chip and AI talent May 3rd, 2024 Vietnam’s Galaxy Education eyes up to $20m fundraising to expand footprint May 3rd, 2024 Sony looks to boost film assets with $26bn Paramount acquisition May 3rd, 2024 Soundwill pushes to revalue Causeway Bay site as demand declines May 3rd, 2024